139 related articles for article (PubMed ID: 38301426)
1. Recent advances in pyruvate dehydrogenase kinase inhibitors: Structures, inhibitory mechanisms and biological activities.
Li Y; Xie Z; Lei X; Yang X; Huang S; Yuan W; Deng X; Wang Z; Tang G
Bioorg Chem; 2024 Mar; 144():107160. PubMed ID: 38301426
[TBL] [Abstract][Full Text] [Related]
2. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
[TBL] [Abstract][Full Text] [Related]
3. Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
Zhang W; Zhang SL; Hu X; Tam KY
Int J Biol Sci; 2015; 11(12):1390-400. PubMed ID: 26681918
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis.
Woolbright BL; Rajendran G; Harris RA; Taylor JA
Mol Cancer Ther; 2019 Oct; 18(10):1673-1681. PubMed ID: 31511353
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.
Sugden MC; Holness MJ
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E855-62. PubMed ID: 12676647
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate.
Ferriero R; Iannuzzi C; Manco G; Brunetti-Pierri N
J Inherit Metab Dis; 2015 Sep; 38(5):895-904. PubMed ID: 25601413
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
Stacpoole PW
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
[TBL] [Abstract][Full Text] [Related]
8. Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation.
Gan L; Yang Y; Liang Z; Zhang M; He Y; Zhang SL
Eur J Med Chem; 2024 Jan; 264():116008. PubMed ID: 38056298
[TBL] [Abstract][Full Text] [Related]
9. Site specificity of four pyruvate dehydrogenase kinase isoenzymes toward the three phosphorylation sites of human pyruvate dehydrogenase.
Korotchkina LG; Patel MS
J Biol Chem; 2001 Oct; 276(40):37223-9. PubMed ID: 11486000
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications.
Wang X; Shen X; Yan Y; Li H
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739396
[TBL] [Abstract][Full Text] [Related]
11. Nematode pyruvate dehydrogenase kinases: role of the C-terminus in binding to the dihydrolipoyl transacetylase core of the pyruvate dehydrogenase complex.
Chen W; Komuniecki PR; Komuniecki R
Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):103-9. PubMed ID: 10085233
[TBL] [Abstract][Full Text] [Related]
12. R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
Korotchkina LG; Sidhu S; Patel MS
Free Radic Res; 2004 Oct; 38(10):1083-92. PubMed ID: 15512796
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Connection of Inflammatory Pain: Pivotal Role of a Pyruvate Dehydrogenase Kinase-Pyruvate Dehydrogenase-Lactic Acid Axis.
Jha MK; Song GJ; Lee MG; Jeoung NH; Go Y; Harris RA; Park DH; Kook H; Lee IK; Suk K
J Neurosci; 2015 Oct; 35(42):14353-69. PubMed ID: 26490872
[TBL] [Abstract][Full Text] [Related]
14. Loss of metabolic flexibility as a result of overexpression of pyruvate dehydrogenase kinases in muscle, liver and the immune system: Therapeutic targets in metabolic diseases.
Jeon JH; Thoudam T; Choi EJ; Kim MJ; Harris RA; Lee IK
J Diabetes Investig; 2021 Jan; 12(1):21-31. PubMed ID: 32628351
[TBL] [Abstract][Full Text] [Related]
15. Development of pyruvate dehydrogenase kinase inhibitors in medicinal chemistry with particular emphasis as anticancer agents.
Zhang SL; Hu X; Zhang W; Yao H; Tam KY
Drug Discov Today; 2015 Sep; 20(9):1112-9. PubMed ID: 25842042
[TBL] [Abstract][Full Text] [Related]
16. The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents.
Saunier E; Benelli C; Bortoli S
Int J Cancer; 2016 Feb; 138(4):809-17. PubMed ID: 25868605
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and structure-activity relationship of novel dichloroacetophenones targeting pyruvate dehydrogenase kinases with potent anticancer activity.
Xu B; Wang ZP; Liu Q; Yang X; Li X; Huang D; Qiu Y; Tam KY; Zhang SL; He Y
Eur J Med Chem; 2021 Mar; 214():113225. PubMed ID: 33550182
[TBL] [Abstract][Full Text] [Related]
18. Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases.
Zhou X; Yu S; Su J; Sun L
Int J Mol Sci; 2016 Mar; 17(3):340. PubMed ID: 26959013
[TBL] [Abstract][Full Text] [Related]
19. Development of dual inhibitors targeting pyruvate dehydrogenase kinases and human lactate dehydrogenase A: High-throughput virtual screening, synthesis and biological validation.
Xiang S; Huang D; He Q; Li J; Tam KY; Zhang SL; He Y
Eur J Med Chem; 2020 Oct; 203():112579. PubMed ID: 32688200
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis.
Flora GD; Nayak MK; Ghatge M; Kumskova M; Patel RB; Chauhan AK
Blood Adv; 2023 Jun; 7(11):2347-2359. PubMed ID: 36971790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
